. Author manuscript; available in PMC: 2012 Oct 2.

Published in final edited form as: Mol Immunol. 2011 Oct 2;49(1-2):367–379. doi: 10.1016/j.molimm.2011.09.008

Table IV.

Bone marrow B cells over-expressing Bright preferentially develop into MZ cells^a.

	FO	MZ	Ratio
CD45.2⁺ B cells splenic B cells (×10⁶)
0% BrTg (100% Control)	35.40±8.70^b	5.66±0.94	6.18
50% BrTg (50% Control)	39.23±1.62	8.47±0.27	4.63
75% BrTg (25% Control)	27.77±2.23	6.99±0.82	4.01
100% BrTg (0% Control)	22.90±3.46	10.65±1.14	2.14

Recipient mice (n = 3 per group) were analyzed after 5 weeks.

Total cell numbers (MEAN±SEM) per spleen were determined by multiplying the frequency of live cells gated as in Figure by the number of total cells per spleen and are shown ×10⁶.